Abiopharma

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

DTS Introduces SLICE6 AIR-TC Thermocouple DAQ for Advanced Flight Testing

Natera - Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Organon & Co. - Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada

Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Alibaba Group Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026

The Confidence Behind VinFasts 10-Year Promise

Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada